FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Search Results

Epinephrine Injection, Auto-Injector
Status: Currently in Shortage
»Date first posted: 05/09/2018
»Therapeutic Categories: Pulmonary/Allergy

Expand all

Adamis Pharmaceuticals Corporation (Revised 05/19/2022)

Company Contact Information:
800-230-3935

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Carton containing two SYMJEPI (epinephrine injection, USP) 0.3 mg single-dose, pre-filled syringes (NDC 78670-130-02))	Available
Carton containing two SYMJEPI (epinephrine injection, USP) 0.15 mg single-dose, pre-filled syringes (NDC 78670-131-02)	Available

Impax Laboratories (Revised 04/28/2021)

Company Contact Information:
877-99-Impax(46729); option 2

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
0.15 mg/0.15 mL epinephrine injection, USP, pre-filled auto-injector (two pack)(NDC 0115-1695-49)	On allocation to current customers.	Dear Healthcare Provider Letter Patient Inspection Instructions	Manufacturing delays
0.3 mg/0.3 mL epinephrine injection, USP, pre-filled auto-injector (two pack)(NDC 0115-1694-49)	On allocation to current customers.	Important Safety Information for Healthcare Providers Important Safety Information for Consumers	Manufacturing delays

Kaleo (Reverified 01/27/2021)

Company Contact Information:
877-30-AUVIQ (1-877-302-8847)

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Carton containing two AUVI-Q (epinephrine injection, USP) 0.3 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-023-01)	Available
Carton containing two AUVI-Q (epinephrine injection, USP) 0.15 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-022-01)	Available
Carton containing two AUVI-Q (epinephrine injection, USP) 0.1 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-021-01)	Available

Mylan Specialty, a Viatris Company (Reverified 07/19/2022)

Company Contact Information:
800-796-9526

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
0.3 mg EpiPen® (NDC 49502-500-02); Authorized Generic (NDC 49502-102-02)	Available	Dear Healthcare Provider Letter: Important Safety Information This letter is to communicate important safety information and is not a recall of the product.
0.15 mg EpiPen® (NDC 49502-501-02); Authorized Generic (NDC 49502-101-02)	Available	Dear Healthcare Provider Letter: Important Safety Information This letter is to communicate important safety information and is not a recall of the product.

Teva Pharmaceuticals (Reverified 07/01/2022)

Company Contact Information:
800-545-8800

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
0.15 MG Epinephrine Injection, USP auto-injector (NDC 0093-5985-27)	Available
0.3 mg/mL epinephrine injection, USP, auto-injector (NDC 0093-5986-27)	Available